全部商机

本商机洞察由 AI 基于公开社区讨论合成生成。我们不展示用户原始帖子或评论原文,所有内容已经过改写聚合。请在实际行动前自行验证。

79
r/algotrading
SaaS subscription
Build

Evidence-Based Factor Screener

Build a SaaS stock screener that ranks indicators by empirical strength, then lets users screen equities using value, quality, and momentum factors with transparent evidence scores. The product should emphasize historical robustness, transaction-cost awareness, and sector-specific behavior rather than hype around any single indicator.

上升 +457%5 个频道30 天提及趋势: latest 3, peak 4, 30-day series
在 Reddit 查看
发现于 2026年6月22日

为什么这很重要

You want to select stocks with methods that have more than a good story behind them, but every indicator seems to have defenders, critics, and conflicting backtests. You can find academic papers, blog posts, and charting tools, yet none of them make it easy to answer a practical question: which signals still look credible after costs, across sectors, and over changing market conditions? If you are not already running your own research stack, you end up stitching together books, spreadsheets, and partial backtests. That creates uncertainty right where confidence matters most: before you commit capital.

  • · 专为 Self-directed investors and serious retail traders who want academically grounded stock screens without building their own quant pipeline. 打造。
  • · 最可能的变现方式:SaaS subscription。

痛点叙事

You want to select stocks with methods that have more than a good story behind them, but every indicator seems to have defenders, critics, and conflicting backtests. You can find academic papers, blog posts, and charting tools, yet none of them make it easy to answer a practical question: which signals still look credible after costs, across sectors, and over changing market conditions? If you are not already running your own research stack, you end up stitching together books, spreadsheets, and partial backtests. That creates uncertainty right where confidence matters most: before you commit capital.

得分构成

痛点强度9/10
付费意愿6/10
实现难度(易构建)6/10
可持续性7/10

市场信号

30 天提及趋势峰值:4
Sparkline: latest 3, peak 4, 30-day series
覆盖频道
algotradingfront_pageproductivityChatGPTsaas

Go-to-Market 启动方案

精确目标用户

Independent investors who already use stock screeners and want more evidence-driven factor selection without writing code.

预估用户数量

~100K-300K active globally

主获客渠道

SEO long-tail

价格锚点

$29/month

首个里程碑

25 paying users from search traffic and finance-community outreach within 30 days

MVP 方案 · 1-2 周

第 1 周
  • Define 10 core factors with formulas and plain-English explanations
  • Connect one market data source and one fundamentals data source
  • Build a simple database schema for prices, fundamentals, and factor scores
  • Create a factor evidence page with research summary, caveats, and cost notes
  • Ship a basic stock screener UI with filters for value and cash-flow metrics
第 2 周
  • Add sector-relative comparisons for each factor
  • Build historical factor performance charts by decile
  • Add simple transaction-cost assumptions to reported results
  • Implement watchlists and saved screens
  • Launch a landing page with one free evidence report to collect emails
MVP 功能: Prebuilt factor library with evidence ratings · Stock screening by value, cash flow, earnings yield, and quality metrics · Sector-relative factor views and historical robustness dashboards

差异化

现有方案
Generic broker charting toolsCustom quant research stacksBooks and academic papers
我们的切入角度
There is room for a user-friendly research and screening product that converts factor evidence, regime testing, and cost-aware validation into a practical decision tool for self-directed investors.

为什么这件事可能失败

自我反驳——最重要的信任度信号

  1. 1The product may be perceived as another generic stock screener unless the evidence layer is clearly differentiated and trusted.
  2. 2Users may not convert if they can replicate core screens using free finance sites and public factor articles.
  3. 3Data licensing costs could compress margins before subscriber volume is high enough.

证据综述

AI 如何合成此洞察——无原话引用

The discussion repeatedly favors value and cash-flow-oriented metrics over common chart indicators when the goal is stock selection. Several participants point to long-horizon factor research, while others warn that technical indicators often degrade after costs or regime changes. There is also repeated interest in combining signals rather than trusting one metric alone, which supports a screener that surfaces evidence, caveats, and implementation context.

1 分析了 1 篇帖子5 5 个频道AI · AI 合成 · 无原话

行动计划

在写代码之前,先验证这个商机

推荐下一步

直接做

需求信号强烈。痛点真实、付费意愿明确——启动 MVP 开发。

落地页文案包

基于真实 Reddit 评论整理的即用文案,可直接粘贴到落地页

主标题

Evidence-Based Factor Screener

副标题

Build a SaaS stock screener that ranks indicators by empirical strength, then lets users screen equities using value, quality, and momentum factors with transparent evidence scores. The product should emphasize historical robustness, transaction-cost awareness, and sector-specific behavior rather than hype around any single indicator.

目标用户

适合:Self-directed investors and serious retail traders who want academically grounded stock screens without building their own quant pipeline.

功能列表

✓ Prebuilt factor library with evidence ratings ✓ Stock screening by value, cash flow, earnings yield, and quality metrics ✓ Sector-relative factor views and historical robustness dashboards

去哪里验证

把落地页链接发布到 r/r/algotrading——这里就是这些痛点被发现的地方。

注册解锁完整深度分析

GTM 计划、MVP 范围、失败原因、ActionPlan Copy Kit。免费注册即可享受 10 次/月详情查看。

报告 / PRDBUSINESS

同主题相关商机

AI 自动从相关讨论中聚类得出

常见问题

谁有这个痛点?
Self-directed investors and serious retail traders who want academically grounded stock screens without building their own quant pipeline.
这是一个真正的机会吗?
此机会在 Pain Spotter 的综合指标(痛点强度、付费意愿、技术可行性和可持续性)中得分为 79/100。在投入工程时间之前,请进一步验证。
我应该如何验证它?
在开发之前,与目标受众进行 5 次客户探索对话,发布带有候补名单的落地页,并检查链接的源帖子以了解近期动态。